Related Experiment Videos
Neonatal jaundice and bilirubin encephalopathy: a clinical and experimental reappraisal
Y Amit1, M J Poznansky, D Schiff
1Department of Pediatrics, University of Alberta, Edmonton, Canada.
Insights
Bilirubin toxicity is a concern in newborns, especially premature infants. However, studies show minimal long-term effects in healthy full-term infants, despite the known risks of hyperbilirubinemia.
Area of Science:
- Neonatal Medicine
- Neuroscience
- Biochemistry
Background:
- Hyperbilirubinemia and bilirubin encephalopathy are recognized neonatal conditions.
- Bilirubin's neurotoxicity is inferred from neurological symptoms associated with high levels.
- While generally considered safe for healthy term infants, bilirubin poses risks to premature infants and those with hemolysis.
Purpose of the Study:
- To review challenges in clinical and experimental studies of bilirubin toxicity.
- To highlight the ongoing uncertainty regarding bilirubin's primary cellular targets despite extensive research.
Main Methods:
- Review of existing clinical and experimental studies on bilirubin toxicity.
- Analysis of factors contributing to inconsistent research findings.
Main Results:
- Long-term consequences of hyperbilirubinemia in healthy term infants show minimal to no bilirubin effect.
- Bilirubin is still regarded as toxic for premature infants and those with hemolysis.
- Inconsistencies in research results stem from varied experimental designs, animal models, cell systems, and unstable bilirubin solutions.
Conclusions:
- The primary target of bilirubin's toxic effects remains unidentified.
- Methodological variations complicate the definitive assessment of bilirubin toxicity.
- Further standardized research is needed to clarify bilirubin's neurotoxic mechanisms.
Abstract:
Hyperbilirubinemia and bilirubin encephalopathy are well-known occurrences in the neonatal period. The fact that bilirubin might be toxic to neural cells stems from the neurological picture that has emerged and the associated hyperbilirubinemia. Studies of the relationship between hyperbilirubinemia in healthy full-term infants and the long-term consequences showed little or no effect of bilirubin. Nevertheless, bilirubin is still considered toxic to premature infants and infants with hemolysis. In addition, in spite of a fairly detailed understanding of the chemistry of bilirubin and the biochemistry of bilirubin metabolism, the primary target of its toxic effect is still not known. The difficulties in analyzing the results are due to the variation in experimental designs, the use of different animal models and cell systems and the use of unstable bilirubin solutions. We review some of the problems related to clinical and experimental studies of bilirubin toxicity.